Marsh & Mclennan Companies (MRSH) Cash & Equivalents (2009 - 2026)

Marsh & Mclennan Companies (MRSH) has 18 years of Cash & Equivalents data on file, last reported at $12.2 billion in Q2 2026.

• Quarterly Cash & Equivalents rose 627.67% year-over-year to $12.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.2 billion (up 627.67% YoY) and the FY2025 annual result came in at $2.7 billion, down 76.17% from the prior year.
• Cash & Equivalents advanced to $12.2 billion in Q2 2026, from $11.7 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $12.2 billion in Q2 2026 to a low of $772.0 million in Q1 2022.
• A 5-year average of $5.1 billion and a median of $2.6 billion in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents surged 1038.97% — and 2025, when it slumped 86.0%.
• Tracing MRSH's Cash & Equivalents over 5 years: stood at $1.4 billion in 2022, then jumped by 132.87% to $3.4 billion in 2023, then soared by 235.8% to $11.3 billion in 2024, then sank by 76.17% to $2.7 billion in 2025, then soared by 354.15% to $12.2 billion in 2026.
• The last three Cash & Equivalents figures came in at $12.2 billion (Q2 2026), $11.7 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.